| Literature DB >> 33666182 |
Paul Frost Clementsen1, Uffe Bodtger2, Lars Konge3, Ida Skovgaard Christiansen4, Rafi Nessar5, Goran Nadir Salih5, Shailesh Kolekar5, Christian Niels Meyer4, Sara Colella6, Christian Jenssen7, Felix Herth8, Michael Hocke9, Christoph Frank Dietrich10.
Abstract
Accurate staging of non-small cell lung cancer (NSCLC) is crucial for allocation to surgical, medical or multimodal treatment. EUS and endobronchial ultrasound (EBUS) have gained ground in the diagnosis and staging of lung cancer in addition to radiological imaging (e.g., computed tomography, fluoroscopy, and magnetic resonance imaging), nuclear medicine techniques (e.g. positron emission tomography, PET), combined techniques (e.g., fluorodesoxyglucosepositron emission tomography scanning), and sonographic imaging including conventional transcutaneous mediastinal and lung ultrasound. By using one single echoendoscope in both the trachea and the esophagus, surgical staging procedures (e.g. mediastinoscopy and video assisted thoracoscopy) can be avoided in a considerable proportion of patients with NSCLC.Entities:
Keywords: diagnosis; echoendoscope; staging
Year: 2021 PMID: 33666182 DOI: 10.4103/EUS-D-20-00139
Source DB: PubMed Journal: Endosc Ultrasound ISSN: 2226-7190 Impact factor: 5.628